283 related articles for article (PubMed ID: 20868274)
21. Human platelet aggregation and degranulation is induced in vitro by L-thyroxine, but not by 3,5,3'-triiodo-L-thyronine or diiodothyropropionic acid (DITPA).
Mousa SS; Davis FB; Davis PJ; Mousa SA
Clin Appl Thromb Hemost; 2010 Jun; 16(3):288-93. PubMed ID: 19903697
[TBL] [Abstract][Full Text] [Related]
22. The induction of myeloma cell death and DNA damage by tetrac, a thyroid hormone derivative.
Cohen K; Abadi U; Hercbergs A; Davis PJ; Ellis M; Ashur-Fabian O
Endocr Relat Cancer; 2018 Jan; 25(1):21-34. PubMed ID: 29018054
[TBL] [Abstract][Full Text] [Related]
23. Actions of L-thyroxine (T4) and Tetraiodothyroacetic Acid (Tetrac) on Gene Expression in Thyroid Cancer Cells.
Davis PJ; Lin HY; Hercbergs A; Mousa SA
Genes (Basel); 2020 Jul; 11(7):. PubMed ID: 32645835
[TBL] [Abstract][Full Text] [Related]
24. Tetrac as an anti-angiogenic agent in cancer.
Schmohl KA; Nelson PJ; Spitzweg C
Endocr Relat Cancer; 2019 Jun; 26(6):R287-R304. PubMed ID: 31063970
[TBL] [Abstract][Full Text] [Related]
25. Thyroid Hormone, Hormone Analogs, and Angiogenesis.
Davis PJ; Sudha T; Lin HY; Mousa SA
Compr Physiol; 2015 Dec; 6(1):353-62. PubMed ID: 26756636
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of pathological retinal angiogenesis by the integrin αvβ3 antagonist tetraiodothyroacetic acid (tetrac).
Yoshida T; Gong J; Xu Z; Wei Y; Duh EJ
Exp Eye Res; 2012 Jan; 94(1):41-8. PubMed ID: 22123068
[TBL] [Abstract][Full Text] [Related]
27. Tetraiodothyroacetic acid-tagged liposomes for enhanced delivery of anticancer drug to tumor tissue via integrin receptor.
Lee S; Kim J; Shim G; Kim S; Han SE; Kim K; Kwon IC; Choi Y; Kim YB; Kim CW; Oh YK
J Control Release; 2012 Dec; 164(2):213-20. PubMed ID: 22664473
[TBL] [Abstract][Full Text] [Related]
28. Nongenomic actions of thyroid hormone.
Davis PJ; Goglia F; Leonard JL
Nat Rev Endocrinol; 2016 Feb; 12(2):111-21. PubMed ID: 26668118
[TBL] [Abstract][Full Text] [Related]
29. Cell-surface receptor for thyroid hormone and tumor cell proliferation.
Davis PJ; Davis FB; Lin HY; Bergh JJ; Mousa S; Hercbergs A; Fenstermaker RA; Ciesielski MJ
Expert Rev Endocrinol Metab; 2006 Nov; 1(6):753-761. PubMed ID: 30754150
[TBL] [Abstract][Full Text] [Related]
30. Thyroid hormone stimulation of extracellular signal-regulated kinase and cell proliferation in human osteoblast-like cells is initiated at integrin alphaVbeta3.
Scarlett A; Parsons MP; Hanson PL; Sidhu KK; Milligan TP; Burrin JM
J Endocrinol; 2008 Mar; 196(3):509-17. PubMed ID: 18310446
[TBL] [Abstract][Full Text] [Related]
31. Small molecule hormone or hormone-like ligands of integrin αVβ3: implications for cancer cell behavior.
Davis PJ; Mousa SA; Cody V; Tang HY; Lin HY
Horm Cancer; 2013 Dec; 4(6):335-42. PubMed ID: 23943159
[TBL] [Abstract][Full Text] [Related]
32. Thyroid hormone as a regulator of tumor induced angiogenesis.
Pinto M; Soares P; Ribatti D
Cancer Lett; 2011 Feb; 301(2):119-26. PubMed ID: 21183275
[TBL] [Abstract][Full Text] [Related]
33. Nongenomic regulation by thyroid hormone of plasma membrane ion and small molecule pumps.
Lin HY; Tang HY; Davis FB; Mousa SA; Incerpi S; Luidens MK; Meng R; Davis PJ
Discov Med; 2012 Sep; 14(76):199-206. PubMed ID: 23021374
[TBL] [Abstract][Full Text] [Related]
34. Molecular mechanisms of actions of formulations of the thyroid hormone analogue, tetrac, on the inflammatory response.
Davis PJ; Glinsky GV; Lin HY; Incerpi S; Davis FB; Mousa SA; Tang HY; Hercbergs A; Luidens MK
Endocr Res; 2013; 38(2):112-8. PubMed ID: 23545000
[TBL] [Abstract][Full Text] [Related]
35. Demonstration of the Receptor Site for Thyroid Hormone on Integrin αvβ3.
Lin HY; Mousa SA; Davis PJ
Methods Mol Biol; 2018; 1801():61-65. PubMed ID: 29892817
[TBL] [Abstract][Full Text] [Related]
36. Novel function of the thyroid hormone analog tetraiodothyroacetic acid: a cancer chemosensitizing and anti-cancer agent.
Rebbaa A; Chu F; Davis FB; Davis PJ; Mousa SA
Angiogenesis; 2008; 11(3):269-76. PubMed ID: 18386142
[TBL] [Abstract][Full Text] [Related]
37. Thyroid hormone regulates adhesion, migration and matrix metalloproteinase 9 activity via αvβ3 integrin in myeloma cells.
Cohen K; Flint N; Shalev S; Erez D; Baharal T; Davis PJ; Hercbergs A; Ellis M; Ashur-Fabian O
Oncotarget; 2014 Aug; 5(15):6312-22. PubMed ID: 25071016
[TBL] [Abstract][Full Text] [Related]
38. Thyroid hormone and anti-apoptosis in tumor cells.
Lin HY; Glinsky GV; Mousa SA; Davis PJ
Oncotarget; 2015 Jun; 6(17):14735-43. PubMed ID: 26041883
[TBL] [Abstract][Full Text] [Related]
39. Molecular Basis of Nongenomic Actions of Thyroid Hormone.
Davis PJ; Leonard JL; Lin HY; Leinung M; Mousa SA
Vitam Horm; 2018; 106():67-96. PubMed ID: 29407448
[TBL] [Abstract][Full Text] [Related]
40. Thyroid hormone inhibition in L6 myoblasts of IGF-I-mediated glucose uptake and proliferation: new roles for integrin αvβ3.
Incerpi S; Hsieh MT; Lin HY; Cheng GY; De Vito P; Fiore AM; Ahmed RG; Salvia R; Candelotti E; Leone S; Luly P; Pedersen JZ; Davis FB; Davis PJ
Am J Physiol Cell Physiol; 2014 Jul; 307(2):C150-61. PubMed ID: 24808494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
